ImmunityBio Stock Soaring Today: Key Catalysts Unpacked
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
Volatile indices reflect rapid price changes, offering both risk and opportunity for traders who monitor momentum and volatility indicators.
12,196 articlesImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
AMD is pursuing a bold AI strategy that could drive material growth in data-center compute. This article breaks down ...
Berkshire Hathaway disclosed a $351.7 million investment in The New York Times, marking a surprising return to tradit...
Analysts warn of a ripple (xrp) crash scenario that could open a buying window for patient investors as whales reposi...
As Omnicom wraps up the 2025 fiscal year, investors want clarity on growth, margins, and capital allocation. This gui...
SoFi’s five-year arc has been a brutal test of conviction: a steep drawdown followed by a rebound as the fintech seek...
Midsize U.S. firms reduced payments to Chinese suppliers in 2025 as tariff policy remained volatile, signaling a broa...
A cybersecurity ETF surged roughly 40% in the last month, signaling a shift in investor sentiment toward AI-enabled d...
As the EV wave grows, two names stand out: Lucid and NIO. This guide weighs their momentum, finances, and risk, helpi...
OpenAI has filed confidential IPO paperwork with the SEC, signaling a public listing could be on the horizon. The mov...
As fuel costs climb, airline stocks stumble and investors reassess 2026 earnings prospects. This piece breaks down wh...
AMD beats just 2030’s earnings target two years ahead as AI-driven data center growth accelerates. Here's what it mea...